Elevated release of inflammatory but not sensory mediators from the urothelium is maintained following epirubicin treatment.

Kang, Sung Hyun; Chess-Williams, Russ; McDermott, Catherine

Kang, Sung Hyun; Chess-Williams, Russ; McDermott, Catherine.

Afiliação

Kang SH; Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, 4229, Australia.
Chess-Williams R; Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, 4229, Australia.
McDermott C; Centre for Urology Research, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, 4229, Australia. Electronic address: camcderm@bond.edu.au.

Eur J Pharmacol ; 863: 172703, 2019 Nov 15.

Article em En | MEDLINE | ID: mdl-31585112

Assuntos

Epirubicina/farmacologia; Mediadores da Inflamação/metabolismo; Urotélio/efeitos dos fármacos; Urotélio/metabolismo; Linhagem Celular; Citocinas/metabolismo; Humanos; Óxido Nítrico/metabolismo; Fatores de Tempo; Urotélio/citologia

Palavras-chave

Adverse effects; Bladder cancer; Epirubicin; Inflammation; Intravesical chemotherapy; Urothelium

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Epirubicina / Mediadores da Inflamação / Urotélio Limite: Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google